ELIEM THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.455 USD | +11.69% |
|
+149.56% | +213.33% |
| 04-11 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
| 04-11 | Top Midday Gainers | MT |
Chart calendar Eliem Therapeutics, Inc.
d9a7c3928132f18cd514bf8c0730bb.3V005Am5hVU2-Ym9WG0F126-UXFFBhAmjaPSJOy1pM4.tioZr2jw92BDr72KLTpDnz30Pi4iTF1q2Oy2fpSN9eO8EF7ccMD1A2ySxA~c4a7fd11072e208316aa2a71feb1b5d0
Past events on Eliem Therapeutics, Inc.
| 2024-04-11 08:30 | Acquisition of Tenet Medicines Inc by Eliem Therapeutics Inc Call |
| 2023-09-12 | International Kv7 Channels Symposium |
| 2023-05-30 | Epilepsy Therapies & Diagnostics Development Conference |
| 2023-05-17 | Annual General Meeting |
| 2023-05-11 16:10 | Q1 2023 Earnings Release |
| 2023-03-26 | RSC BMCS SCI Symposium |
| 2023-03-06 16:10 | Q4 2022 Earnings Release |
| 2022-12-01 11:40 | Evercore ISI HealthCONx Conference |
| 2022-11-16 13:50 | Stifel Healthcare Conference |
| 2022-11-15 10:10 | Guggenheim Immunology and Neurology Conference |
| 2022-11-14 06:10 | Q3 2022 Earnings Release |
| 2022-08-15 06:10 | Interim 2022 Earnings Release |
| 2022-07-21 10:30 | Investor Meeting |
| 2022-05-19 13:00 | Annual General Meeting |
| 2022-05-16 06:10 | Q1 2022 Earnings Release |
| 2022-03-29 09:30 | Stifel CNS Day |
| 2022-03-07 16:10 | FY 2021 Earnings Release |
| 2022-02-18 15:00 | SVB Leerink Global Healthcare Conference |
| 2022-02-16 10:30 | Investor Meeting |
| 2021-12-01 15:05 | Evercore ISI HealthCONx Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -35,7 -38,0 6% | -45,1 -46,3 2.43% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -47,5 -49,9 4.85% | -45,2 -48,2 6.05% |
|
Net income Million USD | Released Forecast Spread | -20,7 | -52,0 -57,5 9.46% | -45,2 -47,4 4.63% |
|
EPS USD | Released Forecast Spread | -5,25 | -4,24 -6,32 32.91% | -1,72 -1,73 0.39% |
| Announcement Date | 21/06/21 | 07/03/22 | 06/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -10,7 -13,0 17.35% | -13,1 -15,2 13.32% | -13,7 -13,1 -4.59% | -8,75 -13,5 34.96% | -9,55 -8,80 -8.57% | -23,4 -7,79 -200.78% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,5 -13,0 18.57% | -13,2 -15,2 12.84% | -14,6 -13,1 -11.42% | -9,68 -13,5 28.01% | -7,76 -8,80 11.8% | -22,3 -7,79 -186.04% |
|
Net income Million USD | Released Forecast Spread | -10,5 -16,0 33.96% | -13,2 -14,8 10.78% | -14,6 -12,4 -18.03% | -9,68 -12,6 23.16% | -7,76 -8,65 10.27% | -22,3 -6,63 -236.28% |
|
EPS USD | Released Forecast Spread | 1,25 -0,63 298.41% | -0,50 -0,56 11.24% | -0,56 -0,47 -20% | -0,37 -0,43 14.45% | -0,29 -0,33 13% | -0,84 -0,25 -236% |
| Announcement Date | 07/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 06/03/23 | 11/05/23 |
More events
Past sector events for Eliem Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ELYM Stock
- Calendar Eliem Therapeutics, Inc.
